Flossbach Von Storch Ag Gilead Sciences, Inc. Transaction History

Flossbach Von Storch Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $211,956 - $246,120	-2,930 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $183,505 - $235,044	2,930 New	2,930 $219,000
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $268,725 - $297,528	-3,770 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $10,672 - $12,528	150 Added 4.14%	3,770 $270,000
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $261,038 - $309,401	3,620	3,620 $293,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Flossbach Von Storch Ag, based on Form 13F filings with the SEC.

Stay updated on Flossbach Von Storch Ag with notifications on news.